Key result
Enhanced ECG monitoring shows no benefit over usual care for 36-month atrial fibrillation detection.
Why the study?
Prolonged ECG monitoring improves paroxysmal AF detection in stroke patients, but most randomized studies had only short follow-up.
Does enhanced and prolonged Holter-ECG monitoring improve atrial fibrillation detection in patients aged ≥60 years with acute ischemic stroke?
RCT (n=402)
Open-label
1:1
Yes
Does enhanced and prolonged Holter-ECG monitoring improve atrial fibrillation detection in patients aged ≥60 years with acute ischemic stroke?
Hazard Ratio: 1.45 (95% CI 0.83–2.51)
Absolute Event Rate: 15% vs 11.1%
p-value: p=0.187
Enhanced and prolonged ECG monitoring in acute ischemic stroke patients leads to earlier detection of clinically relevant atrial fibrillation within the first 6 months, though overall 3-year detection rates were not significantly different.
Favors short-term enhanced monitoring for earlier post-stroke AF detection; challenges sustained long-term superiority over usual care.
BACKGROUND AND PURPOSE: Prolonged electrocardiography (ECG)-monitoring in stroke patients improves the detection of paroxysmal atrial fibrillation (pAF). However, most randomized studies only had short follow-up. We aimed to provide 3-year follow-up data for AF detection and stroke recurrence risk. METHODS: We randomized 402 patients aged ≥60 years with acute ischemic strokes without AF to either enhanced and prolonged monitoring (EPM; 3×10-day Holter-ECG-monitoring) or standard-of-care (≥24 hours ECG-monitoring). The endpoint of the current analysis was AF within 36 months analyzed by intention to treat. Long-term follow-up was performed for 36 months. RESULTS: Two hundred and seventy-four patients (80%) participated in the extended follow-up (median duration of follow-up was 36 months [interquartile range, 12 to 36]). During the first 6 months, more AF was documented in the EPM arm compared to the control arm (13.5% vs. 5.1%; 95% confidence interval, 2.9% to 14.4%; P=0.004). During months 6 to 36, AF was less detected in the EPM intervention arm than in the control arm (2.0% vs. 7.3%; 95% confidence interval, 0.7% to 9.9%; P=0.028). Overall, the detection rate of AF within 36 months was numerically higher within the EPM group (15.0% vs. 11.1%, P=0.30). Numerically less patients in the EPM arm had recurrent ischemic strokes (5.5% vs. 9.1%, P=0.18), transient ischemic attacks (3.0% vs. 4.5%, P=0.44) or died (4.5% vs. 6.6%, P=0.37). CONCLUSIONS: Enhanced and prolonged ECG monitoring increased AF detection during the first six months, but there was significantly more clinical AF during months 6 to 36 observed in the usual-care arm. This suggests that EPM leads to an earlier detection of clinically relevant AF.
No takes yet. Share an insight, caveat, or question.
Wachter et al. (2021) conducted an RCT in Acute ischemic stroke (n=402). Enhanced and prolonged monitoring (EPM) vs. Standard-of-care (≥24 hours ECG-monitoring) was evaluated on Detection of atrial fibrillation within 36 months (HR 1.45, 95% CI 0.83-2.51, p=0.187). Enhanced and prolonged ECG monitoring increased atrial fibrillation detection during the first six months, but overall detection at 36 months was not significantly different compared to usual care (15.0% vs 11.1%, HR 1.45).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: